Learn More
Phoenix Pharmaceuticals Inc PACAP38 Radioligand, I-125 Isotope, High Affinity for PAC1 Receptor
Supplier: Phoenix Pharmaceuticals Inc T05205
I-125 Labeled PACAP38 is a specialized radioligand designed for precise receptor binding assays. It enables detailed study of PACAP38 interactions with PAC1 and other VPAC receptors, supporting research in neuroprotection, neurodevelopment, nociception, and inflammation. This high-affinity product (Kd = 100 pM) offers rapid and saturable membrane binding, making it ideal for investigating diverse physiological functions and potential therapeutic implications in conditions like migraines.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.